BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12702552)

  • 1. The Drg-1 gene suppresses tumor metastasis in prostate cancer.
    Bandyopadhyay S; Pai SK; Gross SC; Hirota S; Hosobe S; Miura K; Saito K; Commes T; Hayashi S; Watabe M; Watabe K
    Cancer Res; 2003 Apr; 63(8):1731-6. PubMed ID: 12702552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.
    Bandyopadhyay S; Wang Y; Zhan R; Pai SK; Watabe M; Iiizumi M; Furuta E; Mohinta S; Liu W; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Hai T; Watabe K
    Cancer Res; 2006 Dec; 66(24):11983-90. PubMed ID: 17178897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression.
    Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Takano Y; Saito K; Piquemal D; Commes T; Watabe M; Gross SC; Wang Y; Ran S; Watabe K
    Oncogene; 2004 Jul; 23(33):5675-81. PubMed ID: 15184886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer.
    Guan RJ; Ford HL; Fu Y; Li Y; Shaw LM; Pardee AB
    Cancer Res; 2000 Feb; 60(3):749-55. PubMed ID: 10676663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and role of Foxa proteins in prostate cancer.
    Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
    Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of tumor metastasis suppressor region on the short arm of human chromosome 20.
    Goodarzi G; Mashimo T; Watabe M; Cuthbert AP; Newbold RF; Pai SK; Hirota S; Hosobe S; Miura K; Bandyopadhyay S; Gross SC; Balaji KC; Watabe K
    Genes Chromosomes Cancer; 2001 Sep; 32(1):33-42. PubMed ID: 11477659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer progression, metastasis, and gene expression in transgenic mice.
    Perez-Stable C; Altman NH; Mehta PP; Deftos LJ; Roos BA
    Cancer Res; 1997 Mar; 57(5):900-6. PubMed ID: 9041192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
    Kauffman EC; Robinson VL; Stadler WM; Sokoloff MH; Rinker-Schaeffer CW
    J Urol; 2003 Mar; 169(3):1122-33. PubMed ID: 12576866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
    Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
    Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13.
    Gao AC; Lou W; Dong JT; Isaacs JT
    Cancer Res; 1997 Mar; 57(5):846-9. PubMed ID: 9041184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.
    Fu Z; Kitagawa Y; Shen R; Shah R; Mehra R; Rhodes D; Keller PJ; Mizokami A; Dunn R; Chinnaiyan AM; Yao Z; Keller ET
    Prostate; 2006 Feb; 66(3):248-56. PubMed ID: 16175585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.
    Darnel AD; Behmoaram E; Vollmer RT; Corcos J; Bijian K; Sircar K; Su J; Jiao J; Alaoui-Jamali MA; Bismar TA
    Clin Cancer Res; 2009 Feb; 15(4):1376-83. PubMed ID: 19228738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the androgen receptor pathway during progression of prostate cancer.
    Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
    Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer.
    Kovacevic Z; Richardson DR
    Carcinogenesis; 2006 Dec; 27(12):2355-66. PubMed ID: 16920733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.
    Freedland SJ; Pantuck AJ; Paik SH; Zisman A; Graeber TG; Eisenberg D; McBride WH; Nguyen D; Tso CL; Belldegrun AS
    Prostate; 2003 Jun; 55(4):299-307. PubMed ID: 12712409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
    Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.